EGFR-specific binding peptide GE11 can guide Let-7a-containing exosomes to EGFR-positive cancer cells, which dramatically inhibited EGFR-positive human breast cancer cell growth in a xenograft mouse model (Ohno et al., 2013). Here, EGFR is linked to breast carcinoma.